1. Home
  2. SCPH vs AKA Comparison

SCPH vs AKA Comparison

Compare SCPH & AKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SCPH
  • AKA
  • Stock Information
  • Founded
  • SCPH 2013
  • AKA 2018
  • Country
  • SCPH United States
  • AKA United States
  • Employees
  • SCPH N/A
  • AKA N/A
  • Industry
  • SCPH Biotechnology: Pharmaceutical Preparations
  • AKA Catalog/Specialty Distribution
  • Sector
  • SCPH Health Care
  • AKA Consumer Discretionary
  • Exchange
  • SCPH Nasdaq
  • AKA Nasdaq
  • Market Cap
  • SCPH 274.7M
  • AKA 251.5M
  • IPO Year
  • SCPH 2017
  • AKA 2021
  • Fundamental
  • Price
  • SCPH $3.43
  • AKA $19.25
  • Analyst Decision
  • SCPH Strong Buy
  • AKA Buy
  • Analyst Count
  • SCPH 2
  • AKA 3
  • Target Price
  • SCPH $15.00
  • AKA $25.00
  • AVG Volume (30 Days)
  • SCPH 494.3K
  • AKA 9.8K
  • Earning Date
  • SCPH 11-13-2024
  • AKA 11-07-2024
  • Dividend Yield
  • SCPH N/A
  • AKA N/A
  • EPS Growth
  • SCPH N/A
  • AKA N/A
  • EPS
  • SCPH N/A
  • AKA N/A
  • Revenue
  • SCPH $30,278,000.00
  • AKA $564,586,000.00
  • Revenue This Year
  • SCPH $195.62
  • AKA $4.56
  • Revenue Next Year
  • SCPH $145.07
  • AKA $3.92
  • P/E Ratio
  • SCPH N/A
  • AKA N/A
  • Revenue Growth
  • SCPH 303.87
  • AKA 3.31
  • 52 Week Low
  • SCPH $3.08
  • AKA $7.00
  • 52 Week High
  • SCPH $6.71
  • AKA $33.73
  • Technical
  • Relative Strength Index (RSI)
  • SCPH 32.05
  • AKA 38.82
  • Support Level
  • SCPH $3.25
  • AKA $18.19
  • Resistance Level
  • SCPH $3.60
  • AKA $21.29
  • Average True Range (ATR)
  • SCPH 0.23
  • AKA 1.90
  • MACD
  • SCPH -0.07
  • AKA -0.51
  • Stochastic Oscillator
  • SCPH 18.95
  • AKA 27.61

About SCPH scPharmaceuticals Inc.

scPharmaceuticals Inc is a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care and reduce healthcare costs. The company's main product is Furoscix. Furoscix consists of this patented formulation of furosemide for subcutaneous administration with wearable, portable sc2Wear Infusor for the treatment of edema in patients with heart failure.

About AKA a.k.a. Brands Holding Corp.

a.k.a. Brands Holding Corp is an online fashion retailer focused on acquiring and accelerating the growth of next-generation, digitally native fashion brands targeting Gen Z and Millennial customers. The brands of the company are two women's brands, Princess Polly and Petal & Pup, and two streetwear brands, Culture Kings and mnml. The company derives maximum revenue from Australia/New Zealand.

Share on Social Networks: